First-in-class diabetes drug launches in UK

A novel class of blood glucose-lowering treatment for type 2 diabetes has launched in the UK after gaining European approval, offering GPs new treatment options.

Finger prick: new class of diabetes drugs approved
Finger prick: new class of diabetes drugs approved

Dapagliflozin (Forxiga) belongs to a new drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidney.

This means it can be prescribed alongside other glucose-lowering drugs, including insulin, when these treatments along with changes in diet and exercise do not provide sufficient blood glucose control. It can also be used as monotherapy when metformin is not tolerated.

A study found reductions in blood glucose with dapagliflozin were similar to those in patients treated with a sulphonylurea plus metformin.

Research has also suggested dapagliflozin plus metformin can also encourage weight loss averaging 3.7kg over two years, compared with weight gain of 1.36kg among patients on sulphonylurea plus metformin.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs should not prescribe opioids, NSAIDs or paracetamol for chronic pain, says NICE

GPs should not prescribe opioids, NSAIDs or paracetamol for chronic pain, says NICE

GPs should not prescribe opioids, benzodiazepines, paracetamol or NSAIDs for chronic...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

GPs told to restore patient activity to pre-pandemic levels in new NHS England guidance

GPs told to restore patient activity to pre-pandemic levels in new NHS England guidance

GP practices have been instructed to increase activity, 'make rapid progress' on...

How to deal with patient requests for face covering exemption letters

How to deal with patient requests for face covering exemption letters

MDU medico-legal adviser Dr Ellie Mein provides advice for GPs on dealing with patients...

Should remote consultations be the default after COVID-19?

Should remote consultations be the default after COVID-19?

Health secretary Matt Hancock has suggested that general practice should follow a...

Government changes self isolation rules for GPs returning from abroad

Government changes self isolation rules for GPs returning from abroad

GPs and other healthcare professionals in England will now be required to self isolate...